AM-IA brings together news, research papers and applications relating to artificial intelligence published around the world into a single feed — and makes them available in your European language at the click of a button.
Scroll to browse · Click to filter
The Pennsylvania health network is expanding its partnership with Hippocratic AI: its agent Ana already handles more than 160,000 calls per month and is out of the appointment scheduling niche.
The Jinfeng laboratory is rolling out six smart diagnostic modules across 50 partner institutions, in a country where there is a shortage of more than 100,000 pathologists.
Since 2 August 2026, most of the requirements of the European AI Act have applied to high-risk AI systems, with specific provisions for medical devices incorporating AI.
Published in *Nature Medicine*, the model learns directly from MRI and CT scans generated over twenty years of routine clinical practice, and outperforms state-of-the-art models in report writing.
Researchers at Texas A&M are training an AI to analyse multimodal patient data in order to identify the stage of Alzheimer’s disease at an earlier stage.
The company details how First Read, its generative AI capable of writing an initial report from chest X-rays, works.
Cognita and Aidoc's tools, which can interpret chest X-rays and write reports, have been granted the FDA's "Breakthrough Device" designation.
The wearable device, combining optical spectroscopy and AI, improves the ability of general practitioners to detect skin cancer by 12.5%.
With assistance, the diagnostic accuracy of eight pathologists increased from 83.2% to 91.7%, and the median analysis time fell by 18.3%.
Trained on more than 30,000 tumors, the UC San Diego model looks for combinations of genetic alterations where conventional biomarkers look at only a few genes.
Rejuvenating cells without turning them into stem cells: this technique, inspired by the work of Nobel Prize winner Shinya Yamanaka, has its most advanced medical application in vision.
Integrated into the patient portal, the tool asks the person about their symptoms and then writes a more complete message, which they are free to modify or ignore before sending.
A model developed by the Mayo Clinic identifies early signs of pancreatic cancer on routine abdominal scans up to three years before clinical diagnosis.
The Mayo Clinic's REDMOD model detects early signs of pancreatic cancer on standard abdominal scans, with a detection rate nearly double that of radiologists alone.
Overview of the players in AI-assisted therapy and the first regulatory signals, as several American states begin to regulate the use of chatbots as substitutes for a therapist.
An AI model called REDMOD detects early signs of pancreatic cancer on simple abdominal scans that are invisible to the naked eye, well before the usual clinical diagnosis.
The drug candidate ISM001-055, targeting idiopathic pulmonary fibrosis, successfully completes a Phase IIa study — a world first for a molecule both discovered and designed by generative artificial intelligence.
Life Biosciences is closing an $80 million Series D to develop an AAV therapy capable of partially rejuvenating aging eye cells.
In five NHS facilities, automatic prioritisation of AI chest X-rays has not shortened either the time to CT scan or the time to lung cancer diagnosis.
A randomised controlled trial with 316 participants in the UK shows that the CBT-based PATH app reduces symptoms of anxiety and depression more than a conventional self-help site.